Advertisement
Grifols, S.A.

Grifols, S.A. (GIFLF) Stock Overview

Explore Grifols, S.A.’s financial performance, market position, analyst ratings, and future outlook.

GIFLFPNK
HealthcareDrug Manufacturers - General
$10.60
$0.30(2.75%)
U.S. Market opens in 16h 44m
Advertisement

Grifols, S.A. (GIFLF)

Meyka AI Score

Z

Key Financials

Market Cap7.2B
P/E Ratio15.78
EPS (TTM)$0.71
ROE0.08%
Fundamental Analysis

AI Price Forecasts

1 Month$13.13
3 Months$14.94
1 Year Target$13.17

GIFLF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Grifols, S.A. (GIFLF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 69.21, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $13.17.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 15.78 and a market capitalization of 7.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-2.75%
5-Day Change
-4.68%
1-Month Change
0.28%
3-Month Change
-17.83%
6-Month Change
-9.09%
Year-to-Date (YTD) Change
-9.09%
1-Year Change
-3.20%
3-Year Change
-15.87%
5-Year Change
-60.83%
All-Time (Max) Change
-99.95%

Contact Information

34 93 571 02 21
Avinguda de la Generalitat, 152, Barcelona, NaN, 08174

Company Facts

23,833 Employees
IPO DateJun 24, 2008
CountryES
Actively Trading

Frequently Asked Questions